22/10/2024
On 19th October, Dr Koh Hong Yi was invited by DKSH and Fullerton Health to speak to its GP partners ððĻð§-ððððŦðĻðĒðððĨ ððð§ðð ððĶðð§ð ðĻð ðððģððĶð and ððŦððððĶðð§ð ðĻð ððĪðĒð§ ððð§ðððŦ ðĒð§ ððĒð§ð ððĐðĻðŦð.
Patients are increasingly aware and worried about the side effects of topical steroids, and topical steroid withdrawal syndrome. While topical steroids still has an important role in eczema treatment, doctors need to address patients' concerns and discuss non-steroidal options. Dr Koh touched on the use of non-steroidal treatments such as tacrolimus, pimecrolimus and crisaborole in the prevention of eczema flares using a ððŦðĻ-ððððĒðŊð ððĐðĐðŦðĻðððĄ. Patients adopting this treatment experience less eczema flares and longer remissions between flares. These treatments have been shown to be safe even in very young children. Dr Koh also shared on latest findings where uncontrolled eczema in infancy may be a risk factor for ððĻðĻð ððĨðĨððŦð ðē later on.
Dr Koh's next talk focused on ððĪðĒð§ ððð§ðððŦ ðĶðð§ðð ððĶðð§ð in Singapore. Non-melanoma skin cancer are amongst the ððĻðĐ ðð cancers in Singapore residents. Surgery, in particular ððĻðĄðŽ ðĶðĒððŦðĻð ðŦððĐðĄðĒð ðŽðŪðŦð ððŦðē is the gold standard treatment for most skin cancers and offers better cure rates with smaller wounds. The doctor also needs to provide treatments for patients who are not keen for surgery, including cryotherapy and topical medications for low risk cancers.
The ended with an interactive Q&A session, and a delightable lunch at Sheraton Towers hotel.ð
